Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

421 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intraperitoneal paclitaxel for patients with primary malignant peritoneal mesothelioma: a phase I/II dose escalation and safety study-INTERACT MESO.
van Kooten JP, Dietz MV, Guchelaar NAD, Brandt-Kerkhof ARM, Koolen SLW, Burger JWA, Mathijssen RHJ, Verhoef C, Aerts JGJV, Madsen EVE. van Kooten JP, et al. Among authors: mathijssen rhj. BMJ Open. 2022 Jun 22;12(6):e062907. doi: 10.1136/bmjopen-2022-062907. BMJ Open. 2022. PMID: 35732399 Free PMC article. Clinical Trial.
Reply to N. Singh et al.
van Leeuwen RWF, van Gelder T, Aerts JG, Mathijssen RHJ. van Leeuwen RWF, et al. Among authors: mathijssen rhj. J Clin Oncol. 2016 Nov 20;34(33):4054. doi: 10.1200/JCO.2016.68.9356. Epub 2016 Oct 31. J Clin Oncol. 2016. PMID: 27551130 No abstract available.
Individualized Tamoxifen Dose Escalation-Letter.
Koolen SL, Bins S, Mathijssen RH. Koolen SL, et al. Clin Cancer Res. 2016 Dec 15;22(24):6300. doi: 10.1158/1078-0432.CCR-16-1967. Clin Cancer Res. 2016. PMID: 27980024 No abstract available.
Association between single-nucleotide polymorphisms and adverse events in nivolumab-treated non-small cell lung cancer patients.
Bins S, Basak EA, El Bouazzaoui S, Koolen SLW, Oomen-de Hoop E, van der Leest CH, van der Veldt AAM, Sleijfer S, Debets R, van Schaik RHN, Aerts JGJV, Mathijssen RHJ. Bins S, et al. Among authors: mathijssen rhj. Br J Cancer. 2018 May;118(10):1296-1301. doi: 10.1038/s41416-018-0074-1. Epub 2018 Apr 26. Br J Cancer. 2018. PMID: 29695768 Free PMC article.
Phase I Study of CC-486 Alone and in Combination with Carboplatin or nab-Paclitaxel in Patients with Relapsed or Refractory Solid Tumors.
Von Hoff DD, Rasco DW, Heath EI, Munster PN, Schellens JHM, Isambert N, Le Tourneau C, O'Neil B, Mathijssen RHJ, Lopez-Martin JA, Edenfield WJ, Martin M, LoRusso PM, Bray GL, DiMartino J, Nguyen A, Liu K, Laille E, Bendell JC. Von Hoff DD, et al. Among authors: mathijssen rhj. Clin Cancer Res. 2018 Sep 1;24(17):4072-4080. doi: 10.1158/1078-0432.CCR-17-3716. Epub 2018 May 15. Clin Cancer Res. 2018. PMID: 29764853 Free PMC article. Clinical Trial.
421 results